Upfront Riociguat and Ambrisentan Combination Therapy for Newly Diagnosed PAH
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Journal of Heart and Lung Transplantation